Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy
American Society of Clinical Oncology, Infectious Diseases Society of AmericaPublished: March 26, 2018
- Key Points
- Triage to Initial Empirical Antibiotic Therapy
- Identification of Candidates for Outpatient Management
- Additional Specific Clinical Criteria That May Be Used to Exclude Oncology Patients Who Have Fever and Neutropenia from Initial Outpatient Care Even with a MASCC Score ≥21
- MASCC Scoring System to Identify Patients With Cancer and Febrile Neutropenia at Low Risk of Medical Complications The Talcott’s Classification
- The Clinical Index of Stable Febrile Neutropenia (CISNE) Includes Six Explanatory Variable Associated with Serious Complications
- And More
Also Found In
You rely on Guideline Central for transparency
Guideline Central and select third party use “cookies” on this website to enhance the user experience.
This technology helps us gather statistical and analytical information to optimize the relevant content for you.
The user also has the option to opt-out which may have an effect on the browsing experience.